Drug Approval | March 25, 2023
Zydus receives final approval from USFDA for Doxepin Hydrochloride Capsules USP, 150 mg
Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety
Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety
Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation)
Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)
Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, (RLD Rexulti) had estimated annual sales of US $1,575 million in the US (IQVIA MAT December 2022)
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Subscribe To Our Newsletter & Stay Updated
